Dovitinib
- CAS No.
- 405169-16-6
- Chemical Name:
- Dovitinib
- Synonyms
- CS-226;TKI-258;CHIR-258;dovitinib;PDovitinib;NCGC00249685;CHIR258 7.7G;Dovitinib base;Unii-I35H55G906;TKI258; CHIR-258
- CBNumber:
- CB11512534
- Molecular Formula:
- C21H21FN6O
- Molecular Weight:
- 392.43
- MDL Number:
- MFCD11870802
- MOL File:
- 405169-16-6.mol
- MSDS File:
- SDS
Density | 1.386 |
---|---|
storage temp. | -20° |
solubility | Soluble in DMSO (up to 30 mg/ml). |
pka | 9.44±0.70(Predicted) |
form | solid |
color | Yellow-green |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months. |
CAS DataBase Reference | 405169-16-6 |
FDA UNII | I35H55G906 |
UNSPSC Code | 12352200 |
NACRES | NA.77 |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H302-H315-H319-H335 | |||||||||
Precautionary statements | P261-P305+P351+P338 | |||||||||
NFPA 704 |
|
Dovitinib price More Price(30)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Cayman Chemical | 15220 | Dovitinib ≥98% | 405169-16-6 | 5mg | $121 | 2024-03-01 | Buy |
Cayman Chemical | 15220 | Dovitinib ≥98% | 405169-16-6 | 10mg | $193 | 2024-03-01 | Buy |
Cayman Chemical | 15220 | Dovitinib ≥98% | 405169-16-6 | 25mg | $313 | 2024-03-01 | Buy |
Cayman Chemical | 15220 | Dovitinib ≥98% | 405169-16-6 | 50mg | $505 | 2024-03-01 | Buy |
Biorbyt Ltd | orb154678 | Dovitinib (TKI258, CHIR258) >99% | 405169-16-6 | 100mg | $606.9 | 2021-12-16 | Buy |
Dovitinib Chemical Properties,Uses,Production
Description
Dovitinib (405169-16-6) is a potent kinase inhibitor. Inhibits FLT3 (IC50 = 1 nM), c-KIT (IC50 = 2 nM), FGFR (IC50 = 8 nM), VEGFR1/2/3 (IC50 = 10 nM), PDGFRβ (IC50 = 27 nM), and CSF-1R (IC50 = 36 nM).1 Active in cell culture and in whole animals. Dovitinib selectively blocks the growth B9 cells transformed by wild type, or activated mutant FGFR3. Induces apoptosis, or sensitizes cells to induction of apoptosis by other means in a variety of cancer cell lines.
Uses
Compound used in treating melanoma
Uses
Dovitinib (TKI258, CHIR-258) is a multitargeted tyrosine kinase inhibitor of FLT3 and c-KIT with IC50 of 1 nM and 2 nM, respectively.
Uses
Dovitinib (TKI258, CHIR258) is a novel multi-target inhibitor for Flt3, c-Kit, FGFR1/3, VEGFR1/2/3, PDGFRα/β with IC50 of 1 nM, 2 nM, 8 nM/9 nM and 10 nM/13 nM/8 nM, 210 nM/27 nM respectively.
Uses
Dovitinib is a receptor tyrosine kinase inhibitor that targets vascular endothelial growth factor-2, basic fibroblast growth factor-1, and platelet-derived growth factor β receptors (IC50s = 65, 11, and 5 nM, respectively). At 0.04 μM, dovitinib can inhibit endothelial cell proliferation and motility. These antiangiogenic effects have been proposed to be the mechanism by which dovitinib inhibits hepatocellular carcinoma growth and metastasis. Dovitinib has been evaluated in clinical trials for the treatment of advanced solid tumors.
Definition
ChEBI: 4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-quinolinone is a N-arylpiperazine.
in vivo
the combination of tigatuzumab and tki258 inhibited huh-7 xenograft tumor growth [3]. tki258 reduced wm tumor progression [4].
target
FLT3
IC 50
FLT3: 1 nM (IC50); c-Kit: 2 nM (IC50); FGFR1: 8 nM (IC50); FGFR3: 9 nM (IC50); VEGFR3: 8 nM (IC50); VEGFR1: 10 nM (IC50); VEGFR2: 13 nM (IC50); PDGFRβ: 27 nM (IC50); PDGFRα: 210 nM (IC50); CSF-1R: 36 nM (IC50)
References
1) Lee et al. (2005), In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models; Clin. Cancer Res., 11 3633 2) Xin et al. (2006), CHIR-258 is efficacious in a newly developed fibroblast growth factor receptor 3-expressing orthotopic multiple myeloma model in mice; Clin. Cancer Res., 12 4908
Dovitinib Preparation Products And Raw materials
Raw materials
Preparation Products
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Shanghai Yingrui Biopharma Co., Ltd. | +86-21-33585366 - 03@ | sales03@shyrchem.com | CHINA | 738 | 60 |
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 33024 | 60 |
career henan chemical co | +86-0371-86658258 +8613203830695 | sales@coreychem.com | China | 29856 | 58 |
Hubei xin bonus chemical co. LTD | 86-13657291602 | linda@hubeijusheng.com | CHINA | 22963 | 58 |
BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19552 | 58 |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 | sales@conier.com | China | 49732 | 58 |
SHANGHAI T&W PHARMACEUTICAL CO., LTD. | +86-021-61551413 +8618813727289 | contact@trustwe.com | China | 5738 | 58 |
Tianjin Xinshengjiahe Science & Technology Development Co,.Ltd | +86-86-22-87899925 +86-8618522618860 | 18522618860@163.com | China | 694 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32268 | 58 |
Dideu Industries Group Limited | +86-29-89586680 +86-15129568250 | 1026@dideu.com | China | 22866 | 58 |
View Lastest Price from Dovitinib manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
![]() |
2025-05-13 | Dovitinib
405169-16-6
|
US $39.00-128.00 / mg | 99.78% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2024-11-26 | Dovitinib
405169-16-6
|
US $0.00-0.00 / kg | 1kg | 99%, Single impurity<0.1 | 1 ton | Nanjing Fred Technology Co., Ltd | |
![]() |
2024-11-01 | CHIR-258(Dovitinib,TKI258)
405169-16-6
|
US $0.00-0.00 / bottle | 1bottle | 98% | 100 bottles | Wuhan Nutra Biotechnology Co.,Ltd |
-
- Dovitinib
405169-16-6
- US $39.00-128.00 / mg
- 99.78%
- TargetMol Chemicals Inc.
-
- Dovitinib
405169-16-6
- US $0.00-0.00 / kg
- 99%, Single impurity<0.1
- Nanjing Fred Technology Co., Ltd
-
- CHIR-258(Dovitinib,TKI258)
405169-16-6
- US $0.00-0.00 / bottle
- 98%
- Wuhan Nutra Biotechnology Co.,Ltd